ThetaPal ThetaPal

Manufacturing / In Vitro, In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA

$15.62

-$0.05 (-0.32%)

1.8 B

Market Cap (Small Cap)

52%

IV Rank

114.4%

Implied Volatility

Aug 05

Next Earnings

Insider Trades

2 buys 19 sells
Date Insider Title Type Shares Value
Jun 09, 2026 Cohen Fred E Other 9,200 $0
Jun 09, 2026 Cohen Fred E Other 13,300 $0
Jun 09, 2026 Verwiel Frank Other 9,200 $0
Jun 09, 2026 Verwiel Frank Other 13,300 $0
Jun 09, 2026 Goff Brian Other 9,200 $0
Jun 09, 2026 Goff Brian Other 13,300 $0
Jun 09, 2026 CHASE WILLIAM J Other 9,200 $0
Jun 09, 2026 CHASE WILLIAM J Other 13,300 $0
Jun 09, 2026 Bhanji Muna Other 9,200 $0
Jun 09, 2026 Bhanji Muna Other 13,300 $0

Politician Trades in NTLA

Date Politician Party Type Amount
Aug 25, 2023 Thomas Richard Carper D Sale $1K-$15K
May 22, 2023 Thomas Richard Carper D Purchase $1K-$15K
Feb 28, 2022 Donald Sternoff Beyer D Sale $21K
Oct 29, 2021 Donald Sternoff Beyer D Sale $1K
Sep 20, 2021 Donald Sternoff Beyer D Sale $1K
Jul 21, 2021 Donald Sternoff Beyer D Sale $10K

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Mar 31, 2026 Q1 2026 -$0.93 -$0.81 +13.1% Beat
Dec 31, 2025 Q4 2025 -$0.97 -$0.83 +14.8% Beat
Sep 30, 2025 Q3 2025 -$1.02 -$0.92 +10.0% Beat
Jun 30, 2025 Q2 2025 -$1.04 -$0.98 +5.6% Beat
Mar 31, 2025 Q1 2025 -$1.31 -$1.10 +15.9% Beat

Track NTLA with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for NTLA and your entire portfolio.